期刊文献+

miR-206/miR-1对乳腺癌干细胞增殖的影响及作用机制 被引量:10

Effects of miR-206/miR-1 on Breast Cancer Stem Cell Proliferation and the Mechanism
在线阅读 下载PDF
导出
摘要 目的探讨上调micro RNA-206(mi R-206)和micro RNA-1(mi R-1)表达对乳腺癌干细胞增殖的影响以及其作用机制。方法采用流式细胞分选技术从乳腺癌细胞株MCF-7中分离出乳腺癌干细胞。实验分为空白对照组、阴性对照组、mi R-206转染组、mi R-1转染组。除空白对照组外,其他各组分别转染阴性对照mimic、hsa-mi R-206 mimic、hsa-mi R-1 mimic。应用实时定量PCR检测mi R-206、mi R-1以及转录因子EVI-1基因的表达水平;Western blot法检测EVI-1蛋白的表达;应用MTT法检测mi R-206、mi R-1对乳腺癌干细胞增殖能力的影响。结果从MCF-7细胞系中分选出CD44+/CD24-/low乳腺癌干细胞,经无血清培养后可以成功传代,用于后续试验;转染hsa-mi R-206 mimic、hsa-mi R-1 mimic 48 h后mi R-206、mi R-1相对表达水平提高,EVI-1m RNA表达水平明显下降;Western blot、MTT结果显示,上调mi R-206和mi R-1表达水平后显著降低EVI-1蛋白的表达,抑制了乳腺癌干细胞增殖能力。乳腺癌干细胞中mi R-206、mi R-1表达水平以及EVI-1蛋白表达水平的差异有统计学意义(P<0.05)。结论上调mi R-206和mi R-1表达能够抑制乳腺癌干细胞增殖能力,其机制可能与下调EVI-1的表达有关。 Objective To investigate the effects of up-regulated miR-206/miR-1 on the proliferation of breast cancer stem cells and the effect mech-anism. Methods Breast cancer stem cells(BCSCs)were isolated from breast cancer cell line MCF-7 by fluorescence-activated cell sorting. Cells in the experiment were divided into the blank control group,the negative control group,the miR-206 group and the miR-1 group. The BCSCs were transfected by negative control mimic,hsa-miR-206mimic and hsa-miR-1mimic in all groups except the blank control group. MiR-206and miR-1 expression levels as well as the transcription factor EVI-1 gene were detected by real time PCR. The expression levels of the transcription factor EVI-1 protein were detected by Western blot. MTT method was used to detect the effects of miR-206 and miR-1 on the proliferation of BCSCs. Results The BCSCs(CD44+/CD24-/low cells)isolated from MCF-7 cell lines were successfully cultured in serum-free medium for subsequent studies. After transfection of hsa-miR-206mimic and hsa-miR-1mimic for 48 hours,miR-206and miR-1relative expression levels increased. EVI-1mRNA ex-pression levels significantly decreased. The results of Western blot and MTT showed that up-regulated expression levels of miR-206 and miR-1 could significantly reduce the expression of EVI-1 protein and inhibited the proliferation of BCSCs. The differences in levels of miR-206,miR-1 and EVI-1 protein were statistically significant(P〈0.05). Conclusion Up-regulated miR-206 and miR-1 expression can inhibit the proliferation ability of BCSCs,which may be related to the down-regulation of EVI-1.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2015年第5期394-399,共6页 Journal of China Medical University
基金 国家自然科学基金(81372812)
关键词 MICRORNA 乳腺癌 肿瘤干细胞 miR-206 MIR-1 microRNA breast cancer tumor stem cell miR-206 miR-1
  • 相关文献

参考文献17

  • 1AL-Hajj M, Wieha MS, Benito-Hernandez A, et al. Prospective iden- tification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA,2003,100(7) :3983-3988.
  • 2Knoop AS, Kudsen H, Balslev E, et al. Retrospetive analysis of topoisomerase II a amplifications and deletions as predictive mark- ers in primary breast cancer patients randomly assigned to cyclo- phosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group [ J ]. J Clin Oneol, 2005,23 (30) : 7483-7490.
  • 3Tanner M, Isola J, Wiklund T, et al. Topoisomerase 1I alpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER- 2/neu- amplified breast cancer: Scandinavian Breast Group Trial 9401 [J ]. J Clin Oncol, 2006,24(16) : 2428-2436.
  • 4Harrison H, Farnie G, Howell SJ, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor[J]. Can- cer Res,2010,70(2) :709-718.
  • 5Guo J, Zhou J, Ying X, et al. Effects of stealth liposomal daunorubi- cin plus tamoxifen on the breast cancer and stem ceils [J]. J Pharm Sci,2010,13(2) : 136-151.
  • 6Sheridan C, Kishimoto H, Fuchs RK, et al. CD44~/CD24- breast can- cer cells exhibit enhanced invasive properties : an early step neces- sary for metastasis [ J ]. Breast Cancer Res, 2006,8 (5) : R59.
  • 7龚继芳,袁艳华,宋国红,余靖,贾军,任军.CD44^+/CD24^(-/low)/ABCG2^-乳腺癌干细胞比例增高与临床治疗相关的探索性研究[J].北京大学学报(医学版),2008,40(5):465-470. 被引量:11
  • 8Sayed D, Abdellatif M. MicroRNAs in development and Physiol Rev, 2011,91 (3) : 827-887.
  • 9Carthew RW, Sontheimer EJ. Origins and mechanisms and siRNAs[J ]. Cell, 2009,136(4) : 642-655. disease[J] of miRNAs.
  • 10Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA- 200c links breast cancer stem cells with normal stem cells [J]. Cell, 2009,138(3) :592-603.

二级参考文献20

  • 1王启俊,祝伟星,邢秀梅.北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J].中华肿瘤杂志,2006,28(3):208-210. 被引量:81
  • 2Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975 - 2005, National Cancer Institute [ OL ]. [ 2008-06- 07 ] http:///seer, cancer, gov/csr/1975_2005/.
  • 3Al-Hajj M, Wicha MS, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci U S A, 2003,100 : 3983 - 3988.
  • 4Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [J]. Nat Rev Cancer, 2005, 5:275-284.
  • 5Raaijmakers MH, de Grouw EP, Heuver LH, et al. Breast cancer resistance protein in drug resistance of primitive CD34 ^+ 38 - cells in acute myeloid leukemia[ J]. Clin Cancer Res,2005,11:2436 - 2444.
  • 6Zhou S, Morris JJ, Barnes Y, et al. Bcrpl gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo[ J]. PNAS, 2002, 99 : 12339 - 12344.
  • 7Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancercells, whereas ABCG2^+ and ABCG2 - cancer cells are similarly rumorigenic[ J]. Cancer Res,2005,65 : 6207 -6219.
  • 8Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype[ J]. Nat Med, 2001, 7 : 1028 - 1034.
  • 9Chaudhary PM, Roninson IB. Expression and activity of P glycoprotein, a muhidrug efflux pump, in human hematopoietie stem cells[J~. Cell, 1991,66:85-94.
  • 10Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters [ J]. Nat Rev Cancer, 2002, 2 : 48 - 58.

共引文献10

同被引文献76

  • 1李宗祥,孙平.蒽贝素联合阿霉素对乳腺癌细胞MCF-7增殖和荷瘤裸鼠肿瘤生长的影响[J].中国生化药物杂志,2014,34(4):4-7. 被引量:3
  • 2Oeffinger KC, Fontham ET, Wender RC. Clinical breastexamination and breast cancer screening guideline-reply[J]. JAMA,2016,315(13) :1404.
  • 3Huang CK,Yang CY, Jeng YM,et al. Autocrine/parac-rine mechanism of interleukin-17B receptor promotesbreast tumorigenesis through NF-icB-mediated antiapop-totic pathway[J]. Oncogene,2014,33(23) :2968-2977.
  • 4Zhou R,Zhou X, Yin Z,et al. Tumor invasion and metas-tasis regulated by microRNA-184 and microRNA-574-5pin small-cell lung cancer [J]. Oncotarget, 2015, 6 (42):44609-44622.
  • 5Cui Z, Tang J, Chen J, et al. Hsa-miR-574-5p negativelyregulates MACC-1 expression to suppress colorectal47.
  • 6Tan Y,Ge G,Pan T,et al. Serum MiRNA panel as poten-tial biomarkers for chronic hepatitis B with persistentlynormal alanine aminotransferase [J]. Clin Chim Acta,2015,451(Pt B) :232-239.
  • 7Li Q. Li X, Guo Z, et al. MicroRNA-574-5p was pivotalfor TLR9 signaling enhanced tumor progression viadown-regulating checkpoint suppressor 1 in human lungcancer[J]. PLoS One,2012,7( 11) :e48278.
  • 8Ji S,Ye G,Zhang J,et al. miR-574-5p negatively regulatesQki6/7 to impact p'catenin/Wnt signalling and the devel-opment of colorectal cancer [J]. Gut, 2013,62 ( 5 ) : 716-726.
  • 9Wang QP,Wang Y, Wang XD,et al. Survivin up-regulatesthe expression of breast cancer resistance protein (BCRP)through attenuating the suppression of p53 on NF-kB ex-pression in MCF'7/5-FU cells[J]. Int J Biochem Cell Bi-ol,2013,45(9) :2036-2044.
  • 10刘浩,曹友德,叶维霞,孙阳阳.miR-206抑制乳腺癌MDA-MB-231细胞Cdc42蛋白表达及其对细胞骨架的影响[J].第三军医大学学报,2010,32(6):568-571. 被引量:4

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部